Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100144, China.
Keralty Hospital, 2500 SW 75Ave. Miami, Florida, 33155, USA.
Aesthetic Plast Surg. 2022 Jun;46(3):1280-1286. doi: 10.1007/s00266-022-02885-9. Epub 2022 May 5.
Abdominoplasty is a major surgical procedure in plastic surgery. It removes excess skin and fat, tightens abdominal muscles and fascia, restores normal abdominal anatomy and reshapes the distorted abdominal contour. According to the statistics released annually by International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, there are more than 900, 000 abdominal wall plastic surgeries performed every year worldwide. However, the most commonly used analgesic methods, such as oral administration, intravenous analgesia and local infiltration anesthesia, do not provide the satisfactory analgesic results. We found that intra-sheath injection of ropivacaine of the rectus abdomen was effective in reducing postoperative pain.
To retrospectively study the analgesic effect of continuous pumping ropivacaine into the intra-sheath space of rectus abdominis after abdominoplasty.
A retrospective study was conducted on 67 patients with total abdominal wall plastic surgery admitted to Plastic Surgery Hospital of Chinese Academy of Medical Sciences from February 2020 to August 2021. The patients were from 25 to 56 years old, with a mean age of 38.5, ASA grade 1-2, BMI 27-33kg/m2, and rectus abdominis muscle separation range of 4-8cm. Based on the methods of postoperative analgesia, we divided patients into the following two groups: 29 patients in the conventional intravenous analgesic group (group A) and 38 patients in the rectus abdominis intrathecal analgesic group (group B). Group A received PCA with sufentanil 1.0μg/kg+ normal saline diluted to 100ml. Group B received continuous pumping of ropivacaine (0.2625%) through the rectus sheath internal tube in 100mL of normal saline and continued pumping at a rate of 2mL /h. Visual analog pain score (VAS score), analgesic pump pressure times and the degree of postoperative satisfaction were recorded at T1 (24h) and T2 (48h). The incidence of adverse drug reactions and complications related to nerve block within one week after operation were also recorded.
The clinical data of patients with total abdominal wall plastic surgery in two groups were collected and analyzed. The patients in group B overall had lower postoperative VAS score, less analgesic pump usage, less nausea, vomiting, drowsiness and restlessness and a higher degree of postoperative satisfaction than those in group A.
Continuous pumping of ropivacaine through rectus sheath can effectively relieve postoperative pain, reduce postoperative adverse reactions and improve postoperative satisfaction.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online instructions to Authors www.springer.com/00266 . Body Contouring LOE IV.
腹部整形术是整形外科学中的一项主要手术。它可以去除多余的皮肤和脂肪,收紧腹部肌肉和筋膜,恢复正常的腹部解剖结构,并重塑变形的腹部轮廓。根据国际美容整形外科学会(ISAPS)2020 年公布的年度统计数据,全球每年有超过 90 万例腹壁整形手术。然而,最常用的镇痛方法,如口服、静脉镇痛和局部浸润麻醉,并没有提供满意的镇痛效果。我们发现,腹直肌鞘内注射罗哌卡因对减轻术后疼痛有效。
回顾性研究腹部整形术后连续泵注罗哌卡因至腹直肌鞘内的镇痛效果。
对 2020 年 2 月至 2021 年 8 月在中国医学科学院整形外科医院行全腹壁整形术的 67 例患者进行回顾性研究。患者年龄 25-56 岁,平均年龄 38.5 岁,ASA 分级 1-2 级,BMI 27-33kg/m2,腹直肌分离范围 4-8cm。根据术后镇痛方法,将患者分为以下两组:29 例常规静脉镇痛组(A 组)和 38 例腹直肌鞘内镇痛组(B 组)。A 组接受舒芬太尼 1.0μg/kg+生理盐水稀释至 100ml 的 PCA。B 组在 100ml 生理盐水中通过腹直肌鞘内管连续输注罗哌卡因(0.2625%),以 2ml/h 的速度持续输注。记录 T1(术后 24 小时)和 T2(术后 48 小时)时的视觉模拟疼痛评分(VAS 评分)、镇痛泵按压次数和术后满意度。还记录了术后一周内与神经阻滞相关的药物不良反应和并发症的发生率。
收集并分析了两组患者的腹壁整形术临床资料。B 组患者术后 VAS 评分总体较低,镇痛泵使用次数较少,恶心、呕吐、嗜睡和躁动较少,术后满意度较高。
通过腹直肌鞘连续输注罗哌卡因可有效缓解术后疼痛,减少术后不良反应,提高术后满意度。
证据水平 IV:本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学分级的更详细描述,请参阅目录或在线向作者说明 www.springer.com/00266 。身体塑形 LOE IV。